CALL/TEVA PHARMACEUTICAL INDUSTRIES/8/1/17.01.25 Share Price

Warrant

DE000GP201E2

Market Closed - BOERSE MUENCHEN 07:56:29 19/06/2024 pm IST
8.75 EUR -0.11% Intraday chart for CALL/TEVA PHARMACEUTICAL INDUSTRIES/8/1/17.01.25
Current month+3.43%
1 month+10.34%
Date Price Change
19/24/19 8.75 -0.11%
18/24/18 8.76 -1.35%
17/24/17 8.88 +0.34%
14/24/14 8.85 -1.34%
13/24/13 8.97 +1.24%

Real-time BOERSE MUENCHEN

Last update June 19, 2024 at 07:56 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer Goldman Sachs
WKN GP201E
ISINDE000GP201E2
Date issued 29/03/2023
Strike 8 $
Maturity 17/01/2025 (212 Days)
Parity 1 : 1
Emission price 2.35
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 9.15
Lowest since issue 1.516
Delta0.97x
Omega 1.760
Premium2.16x
Gearing1.81x
Moneyness 2.126
Difference Strike -9.01 $
Difference Strike %-112.63%
Spread 0.05
Spread %0.57%
Theoretical value 8.725
Implied Volatility 62.85 %
Total Loss Probability 8.033 %
Intrinsic value 8.383
Present value 0.3416
Break even 17.38 €
Theta-0.02x
Vega0.01x
Rho0.04x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
17.01 USD
Average target price
18.34 USD
Spread / Average Target
+7.80%
Consensus